Product Information
Name:CDK7-IN-26
Brand:Targetmol
Description:CDK7-IN-26 (compound 36) is an orally active CDK7 inhibitor with an IC50 of 7.4 nM. The compound effectively suppresses the growth of xenograft tumors derived from triple-negative breast cancer (TNBC) cell lines in vivo and has an IC50 of 0.15 μM for inhibiting MDA-MB-453 cells in vitro.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:468.49
Formula:C22H22FN6OPS
Technical inquiry about: CDK7-IN-26
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.